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Highlights: 
 The vast majority of peroxisomal matrix proteins are homo-oligomers. 
 How these proteins are sorted to the organelle has been a matter of debate. 
 We argue that this sorting pathway is best explained by a monomer-based import 
mechanism. 
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Abstract 
 
In the field of intracellular protein sorting, peroxisomes are most famous by their 
capacity to import oligomeric proteins. The data supporting this remarkable property 
are abundant and, understandably, have inspired a variety of hypothetical models on 
how newly synthesized (cytosolic) proteins reach the peroxisome matrix. However, 
there is also accumulating evidence suggesting that many peroxisomal oligomeric 
proteins actually arrive at the peroxisome still as monomers. In support of this idea, 
recent data suggest that PEX5, the shuttling receptor for peroxisomal matrix proteins, is 
also a chaperone/holdase, binding newly synthesized peroxisomal proteins in the 
cytosol and blocking their oligomerization. Here we review the data behind these two 
different perspectives and discuss their mechanistic implications on this protein sorting 
pathway. 
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“No part of the world can simply be read - it always must be interpreted, and those 
interpretations are subject to constant reevaluation.”  
Mark Ptashne [1] 
 
1. Introduction 
Peroxisomes are round-shaped organelles delimited by a single membrane. Their 
size, number and protein repertoire varies widely among organisms, cell types and even 
physiological conditions [2]. In mammals, peroxisomes have a relatively simple 
composition comprising about 100 different proteins [3,4]. Despite this simplicity, 
peroxisomes are involved in important metabolic pathways and, accordingly, mutations 
in genes encoding  peroxisomal enzymes, peroxisomal membrane metabolite 
transporters, or proteins involved in peroxisome biogenesis cause devastating diseases 
in humans [5,6]. 
 All peroxisomal matrix proteins are synthesized in the cytosol and post-
translationally transported to the organelle [7]. Their specific sorting to this 
compartment is mediated by a complex machinery comprising a core of 10 evolutionary 
conserved peroxins (peroxins are proteins specifically involved in peroxisomal 
biogenesis) plus a set of additional proteins most of which are involved in ubiquitin 
conjugation and deconjugation ([8–13]; see also Table I in ref. [14], this issue).  
In order to be sorted to the peroxisome matrix, a newly synthesized protein 
must have a peroxisomal targeting signal (PTS) in its polypeptide chain. There are two 
well-characterized types of PTSs: the PTS type 1 (PTS1), the most common, is a small 
peptide present at the C termini of proteins and frequently ends with the sequence S-K-
L [15]; the PTS2 is a degenerated nonapeptide found at the N termini of a few 
peroxisomal proteins [16,17]. Unlike the PTS1, which is not processed upon import, the 
PTS2 is generally cleaved when the protein reaches the peroxisome matrix of higher 
eukaryotes [17]. 
In mammals, plants and many other organisms, sorting of both PTS1- and PTS2-
containing proteins requires PEX5 [18–22], a monomeric protein of about 70 kDa 
possessing an intrinsically disordered N-terminal half and a globular C-terminal half 
comprising six tetratricopeptide repeat motifs (hereafter simply referred to as TPRs) 
[23–26]. Our knowledge on how PEX5 interacts with these two types of cargoes is still 
fragmented. Structural and protein-protein interaction studies have shown that the 
PTS1 signal interacts with the TPRs of PEX5 [25,27–29]. However, it is now clear that the 
PEX5-cargo protein interaction is not limited to this binding interface and that the N-
terminal half of PEX5 and other regions of the PTS1 cargo proteins are also involved [30–
34]. Much less is known on the PEX5-PTS2 cargo protein interaction. Actually, until 
recently, it was frequently considered that the PEX5-PTS2 interaction might even not be 
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direct but rather bridged by PEX7, a WD-repeat protein long-known to interact with 
both the PTS2 peptide and a small domain present in the N-terminal half of PEX5 [18–
22,35]. However, recent structural data of a trimeric protein complex comprising yeast 
PEX7, an artificial PTS2 protein and a small fragment of PEX21 (the yeast orthologue of 
mammalian/plant PEX5 in the PTS2-mediated protein import pathway; [36,37]), 
revealed that PEX21 also interacts directly with the PTS2 peptide [38]. Given the 
functional and structural similarities between yeast PEX21 and the N-terminal half of 
mammalian/plant PEX5 [36,37], it is therefore likely that the same is valid for 
mammalian/plant PEX5. In agreement with this possibility, two recent studies have 
shown that the human PEX7.PTS2 interaction is drastically stabilized by PEX5 [39,40]. 
One of the most important properties of PEX5 and PEX7 regards their 
intracellular localization. Indeed, in contrast to all the other peroxins involved in this 
protein sorting pathway, which are peroxisomal proteins, pioneering studies on PEX5 
and PEX7 revealed that both display a dual subcellular localization, cytosolic and 
peroxisomal [41,42]. This property, together with their capacity to bind PTS1 and PTS2 
proteins, is at the basis of a central concept found in all mechanistic models published to 
date, namely, that newly synthesized peroxisomal matrix proteins are recognized in the 
cytosol and transported to the organelle by the shuttling receptors PEX5/PEX7; after 
delivering their cargoes into the organelle, the receptors return to the cytosol to 
promote additional rounds of protein transport [41,42]. 
Another important early discovery that has heavily influenced models on the 
mechanism of protein transport to the peroxisome matrix was the observation by 
several researchers that these organelles can acquire already oligomerized proteins 
from the cytosol (see Section 3.). Two main models were then proposed to explain this 
remarkable capacity of peroxisomes [43]. One, a translocation-based model, postulated 
the existence of large regulated channels/pores at the peroxisomal membrane; the 
other, proposed that large already-oligomerized cargo proteins might reach the 
peroxisomal matrix by an endocytosis-like mechanism. Data clearly favoring the 
translocation-based model came a few years later from the biochemical characterization 
of peroxisome-associated PEX5. Indeed, it was found that during its transient passage 
through the peroxisome, PEX5 acquires a transmembrane topology, exposing a small N-
terminal domain into the cytosol whereas the bulky part of its polypeptide chain faces 
the organelle matrix [44,45]. Since the main cargo protein-binding domain of PEX5, the 
TPRs, resides at its C terminus and occupies about half of PEX5 polypeptide chain, this 
finding immediately suggested that cargo proteins are translocated across the organelle 
membrane by PEX5 itself when the receptor becomes inserted into a transmembrane 
protein complex of the peroxisome, the docking/translocation machinery (DTM)[44,46]. 
Subsequent characterization of the insertion of PEX5 into the DTM revealed that this 
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step is a cargo-dependent but ATP-independent process, strongly suggesting that the 
driving force for protein translocation across the organelle membrane derives from 
strong protein-protein interactions involving PEX5 on one side and peroxins of the DTM 
on the other [46–48]. 
Although it is now generally accepted that peroxisomal proteins reach the 
organelle matrix using a translocation-based mechanism [8–10,49–51], there are still 
many questions (and disputes among researchers in the field) on the architecture and 
mechanism of the machinery that accomplishes this task. One of these questions 
regards precisely one of the most famous properties of peroxisomes, i.e., their capacity 
to import already oligomerized proteins. Although the data supporting this property are 
abundant, several findings made over the years suggest that import of already 
oligomerized proteins may not be that frequent and that many of these proteins may 
actually arrive at the organelle still as monomers.  
Here we summarize and discuss the main data behind these two different 
perspectives. As it will be apparent below, many of the points we raise argue against an 
oligomeric protein import model favoring instead a monomeric protein import model. 
This is not to say that the oligomeric protein import model is not valid at all. Actually, for 
a few components of the peroxisome, the oligomeric protein import model still provides 
the best explanation for their presence in the organelle. Ultimately, our goal is to 
stimulate research on this topic so that the peroxisomal protein import machinery stops 
being one of the least understood protein import machineries of the eukaryotic cell. 
 
2. Peroxisomal matrix proteins: the first events after synthesis 
As stated in the previous section, peroxisomal matrix proteins are synthesized on 
soluble cytosolic ribosomes [7]. Thus, as with many other proteins that do not follow the 
secretory pathway, folding of their polypeptide chains is catalyzed by the cytosolic 
chaperone machinery and probably starts as soon as the first N-terminal amino acid 
residues emerge from the ribosomal polypeptide exit tunnel [52–58]. What happens to 
these proteins in the first seconds after folding has not been explored in detail. 
Nevertheless, it is reasonable to assume that peroxisomal matrix proteins that are 
monomers in their native state are simply recognized by cytosolic PEX5/PEX7 and 
transported to the organelle. However, for proteins that are homo-oligomers in their 
native conformation, the pathway may be different, as explained below. 
An interesting property of several peroxisomal homo-oligomeric proteins regards 
the fact that they can be detected as soluble monomeric proteins immediately after 
synthesis, both in vivo [59–61] and in vitro [34,62,63]. This behavior suggests, on one 
hand, that these monomers are already at least partially folded and, on the other, that 
folding of monomers and their oligomerization to yield the native enzymes are not 
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physically coupled events. The same conclusion is probably valid for monomer folding 
and monomer-PEX5 interaction because some active oligomeric peroxisomal proteins 
can be detected in the cytosol of cells lacking PEX5 [64–66] and the in vitro protein 
synthesis system used in the experiments referred to above has essentially no 
endogenous PEX5 [34,62,63]. Thus, it appears that newly synthesized proteins are 
released by the cytosolic chaperone machinery as soluble monomeric proteins 
independently of PEX5. An obvious implication of this reasoning is that all subsequent 
protein-protein interactions occurring in the cytosol are probably of stochastic nature. If 
so, one can consider two possible pathways for these proteins: 1) interaction with 
PEX5/PEX7 and/or 2) oligomerization. The first pathway leads us to a “monomeric 
protein import model” whereas the second is the basis of an “oligomeric protein import 
model” (see Figure 1). Determining which pathway prevails is not a mechanistic detail of 
minor importance because, at the very least, it can provide us with valuable information 
on how the peroxisomal DTM functions. 
 
3. Evidence for the oligomeric protein import model 
The experimental evidence behind the concept that peroxisomal matrix proteins 
oligomerize in the cytosol before import into the organelle dates back to 1994 [43,67]. 
The experiments reported in those two studies consisted of expressing in the same cells 
two versions of a protein, which is homo-oligomeric in its native state. One version 
contained a PTS whereas the other lacked such a signal. Expression of the PTS-less 
protein alone resulted in its cytosolic localization, as expected. However, when this 
protein was co-expressed with the PTS-containing version, the two proteins were now 
found in the peroxisome. Apparently, the protein lacking the PTS was transported to the 
organelle piggy-backed with its PTS-containing partner. Similar findings were 
subsequently reported for other peroxisomal oligomeric proteins in several 
organisms/cell lines (see Table 1). There are three aspects of those experiments that 
deserve discussion. First, with only a few exceptions (see Section 6.), all these studies 
used experimental conditions that lead to very high levels of the characterized proteins. 
As discussed recently, these conditions can potentially lead to the titration of the 
peroxisomal protein import machinery (PIM), and thus to the ectopic (i.e., cytosolic) 
oligomerization of the reporter proteins [63]. Second, in only one case was the import 
kinetics of the reporter oligomeric protein documented [43]. Significantly, the authors 
found that in contrast to endogenous peroxisomal proteins, which display half-lives of 
import of a few minutes, import of the oligomeric reporter protein occurred over a 
period of many hours. From the several possibilities that were considered to explain this 
finding, one was that the import of oligomeric proteins may be an intrinsically low 
efficiency process [43]. Finally, by co-expressing a PTS-containing protein together with 
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its PTS-less version, these experiments create an artificial situation in which a protein 
destined to the peroxisome, and that, therefore, should interact only with its receptor, 
can now also interact with a protein that is not recognized by PEX5/PEX7, and thus be 
rerouted into a non-natural pathway. Although a situation of this type may actually 
occur in a few cases (see Section 6.), most, if not all, newly synthesized subunits of 
oligomeric peroxisomal matrix proteins have PTSs, and thus they all can potentially 
interact with cytosolic PEX5/PEX7. 
In addition to the co-expression experiments described above, two pulse-chase 
analyses in yeasts were reported, both also pointing to the idea that some peroxisomal 
proteins (but not all; see Section 4.) arrive at the peroxisome after oligomerization in 
the cytosol [68,69]. Indeed, at short times after pulse-labeling the cytosolic pools of 
both Candida boidinii dihydroxyacetone synthase and Yarrowia lipolytica acyl-Coa 
oxidase (ACOX) were found to be already in their oligomeric forms. These pools 
decreased during subsequent chase incubations with the concomitant appearance of 
the two proteins in organelle fractions. Although these pulse-chase approaches are 
much more elegant than the co-expression experiments, it should be noted that the 
experimental conditions used in those studies also lead to a drastic proliferation of 
peroxisomes, and thus the criticism raised above regarding a potential titration of the 
PIM also applies here. Another issue with these experiments regards the fact that it is 
difficult to exclude the possibility that oligomerization of the proteins studied occurred, 
not in vivo, during the pulse-chase labeling, but rather during processing of the samples 
for biochemical analyses. 
Another argument that was used to support the concept that peroxisomal 
proteins arrive at the organelle matrix already in their oligomeric state was based on the 
idea that peroxisomes seemed to lack their own protein folding machinery [54,69,70]. 
Thus, peroxisomal proteins should first undergo folding and oligomerization in the 
cytosol, a subcellular compartment where chaperones are abundant, and only then be 
imported into the organelle. However, we now know that peroxisomes from several 
organisms do harbor some protein chaperone activity [71–73]. Furthermore, it is 
conceptually feasible that a newly synthesized protein can acquire a near native 
conformation in the cytosol in a chaperone-mediated process, be imported into the 
organelle still as a monomer and oligomerize in the peroxisomal matrix in a 
spontaneous, unassisted manner (see also ref.[69]). 
Regardless of the criticisms that may or not be raised over the evidence 
supporting the oligomeric protein import model, it must be noted that all that work 
ended up revealing a property of the PIM of paramount importance for the 
comprehension of its mechanism. Indeed, the finding that peroxisomes can import 
already oligomerized proteins demonstrated that the peroxisomal protein import 
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machinery can accept already folded proteins as substrates. This property contrasts with 
those of other protein import machineries, such as the ones found in mitochondria or 
the endoplasmic reticulum, which require their substrates to be unfolded [74,75]. 
Clearly, the peroxisomal protein import machinery abides by different principles. 
 
4. Evidence for the monomeric protein import model 
The first evidence supporting the idea that peroxisomal proteins arrive at the 
organelle matrix still as monomers, come from a pulse-chase analysis of rat liver 
catalase, a homotetrameric protein comprising 15% of the total protein mass of liver 
peroxisomes [61]. The authors found that at short times after labeling, newly 
synthesized catalase was detected in the cytosol as a monomeric inactive protein. This 
pool was subsequently imported into peroxisomes (half-time of import of 14 min) where 
it could be found still in a monomeric state; its oligomerization occurred inside the 
organelle. A similar pulse-chase analysis of C. boidinii alcohol oxidase (AO), an octameric 
protein in its native state, yielded essentially the same conclusion – the protein was 
detected in the cytosol as a monomer and the octameric form could be detected only in 
peroxisomes at later time points [59,69]. 
In vitro import assays aiming at comparing the import efficiencies of monomeric 
and oligomeric versions of three different proteins also pointed into the same direction: 
the monomeric versions of Cucurbita pepo isocitrate lyase, mouse ACOX1 and urate 
oxidase (UOX) were found to be better import substrates than the corresponding 
oligomeric forms [56,63]. Actually, for ACOX1 and UOX no evidence for in vitro import of 
their oligomeric forms could be obtained [63]. 
 Several other observations support the notion that peroxisomal proteins may 
reach the organelle matrix still as monomers (see Table 2). First, there is an increasing 
number of peroxisomal proteins which do not interact with PEX5 upon oligomerization 
[76–78]. The simplest way to explain their peroxisomal localization is to consider that 
these proteins are recognized and transported to the organelle before oligomerization 
(see also Section 5.). If this is so, then why should it be different for all the other 
oligomeric peroxisomal proteins? Some recently described properties of mammalian 
PEX5 suggest that it is not. First, the concentration of cytosolic PEX5 in a rat hepatocyte 
is similar to the sum of cytosolic concentrations of all newly synthesized peroxisomal 
proteins that are en route to the organelle [34]. Thus, all newly synthesized proteins 
could potentially interact with PEX5 shortly after their synthesis/folding. Second, it has 
been shown that PEX5 interacts quite efficiently with the monomeric versions of human 
catalase and mouse sterol carrier protein x, ACOX1 and UOX, four prominent oligomeric 
proteins of liver peroxisomes [34,62,63]. Actually, in the case of catalase, the interaction 
between its monomeric version and PEX5 seems to be much stronger than the 
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interaction between the tetrameric enzyme and PEX5 [34]. Finally, for the three proteins 
found to oligomerize in vitro, it was shown that binding to PEX5 and homo-
oligomerization are mutually exclusive events. The latter two PEX5 properties led us to 
propose that PEX5, in addition to its role as a receptor and translocator for peroxisomal 
matrix proteins, is also a chaperone/holdase that binds newly synthesized monomeric 
proteins in the cytosol avoiding premature or unspecific interactions. 
 
5. Monomeric vs. oligomeric protein import model 
If peroxisomes can import oligomeric proteins why then should this not be the 
regular pathway? After all, if a single PEX5 molecule could transport an oligomeric 
protein to the peroxisomal matrix, instead of its subunits, one by one, such a pathway 
would surely save ATP to the cell (the ATP-consuming step of this protein sorting 
pathway resides in the extraction of the receptors from the DTM; [47,79,80]). The 
problem with this perspective is that it fails to provide plausible explanations for an 
increasing number of observations. For instance, as already stated above, it is difficult to 
envisage how those oligomeric proteins that no longer expose their PTSs might be 
imported into the peroxisome. Naturally, one could assume that there are specific 
cytosolic chaperones that recognize these oligomeric proteins and pull their PTSs out of 
their globular bodies allowing PEX5 to recognize them [81]. However, no evidence for 
the existence of these chaperones was ever obtained, quite the contrary. Indeed, when 
two of these oligomeric proteins are placed in the cytosol of cells either by exploring the 
properties of a yeast temperature-sensitive pex1 mutant [78] or simply by protein 
transfection of mammalian cells [76], they remain in the cytosol. The monomeric 
protein transport model makes no such assumption. It just builds on the experimental 
data described above suggesting that a monomeric soluble protein harboring a PTS1 can 
interact with PEX5, that this interaction blocks its subsequent oligomerization and that 
there is sufficient PEX5 in the cell cytosol to bind all newly synthesized peroxisomal 
proteins.  
Another difference between the two models regards the predictions they make 
at downstream steps, namely those that occur at the peroxisomal DTM. One model 
proposes that a single PEX5 molecule carrying a single cargo protein docks at and gets 
inserted into the peroxisomal membrane DTM, releasing the cargo protein into the 
organelle matrix [82]. Regardless of the cargo protein size, which may be as small as 15 
kDa (e.g., sterol carrier protein 2) or as large as 270 kDa (e.g., xanthine oxidase), such a 
model predicts that a reasonably flexible DTM with a single fixed geometry could deal 
with all peroxisomal matrix proteins (note that for globular/spherical proteins the 
diameter of a 270-kDa protein is only 2.6-fold larger than that of a 15-kDa protein). In 
contrast, the oligomeric protein import model raises the possibility that many of the 
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cargoes that arrive at the DTM, do so bound to several PEX5 molecules [70,83,84]. We 
could assume that only one of these PEX5 molecules, the first to collide with the DTM, 
becomes inserted into the DTM thus pushing the oligomeric cargo protein across the 
peroxisomal membrane; but, if so, what happens then to the other PEX5 molecules that 
may remain bound to the cargo? Are they translocated into the peroxisome matrix 
together with the cargo? Or is there a mechanism to avoid that these PEX5 molecules 
enter the organelle? Alternatively, we could assume that all PEX5 molecules bound to an 
oligomeric cargo protein contribute to cargo translocation, i.e., that they all become 
inserted into the DTM. This would require a DTM with the capacity to interact with 
PEX5-cargo protein complexes displaying rather different geometries, from a 1:1 PEX5-
monomeric cargo protein complex, to linear and V-shaped PEX5-cargo-PEX5 complexes, 
to complexes containing three or more PEX5 molecules, some of which might not even 
exist in a single dimensional plane. Does such machinery exist? No answers have yet 
been provided for these questions. 
 
6. Some proteins are imported as hetero-oligomers under conditions where PIM 
components are not limiting 
The PEX5 properties described above suggest that many newly synthesized 
oligomeric peroxisomal proteins will remain in the monomeric state in the cytosol, as 
long as the amount of PEX5 does not become stoichiometrically limiting. However, the 
stochastic nature of the PEX5-cargo protein interaction also implies that whenever PEX5 
is limiting, cytosolic folded monomers can follow a homo-oligomerization pathway, as is 
probably the case in experiments where the levels of some peroxisomal proteins are 
dramatically increased (see Section 3.). There are, however, three cases where import of 
oligomers occurs under conditions where there are no reasons to believe that PEX5 or 
other components of PIM are stoichiometrically limiting. One regards rat liver Cu/Zn 
superoxide dismutase 1 (SOD1) [85]; another, the two isoforms of human lactate 
dehydrogenase (LDH), LDHA and LDHB [86]; the third, the yeast nicotinamidase Pnc1p 
[87]. Indeed, none of these proteins possess a PTS. Yet, a fraction of them can be found 
in peroxisomes [88–91]. How do these proteins reach the organelle? For SOD1 it was 
shown that one of its chaperones, copper chaperone of SOD1 (CCS), does possess a 
PTS1 whereas for LDH it was recently found that translational readthrough of the stop 
codon in the LDHB transcript yields an extended isoform of this protein, the so-called 
LDHBx, which possesses a PTS1 and can form heterotetramers with both LDHA and 
LDHB [85,86]. Likewise, yeast Pnc1p was recently shown to interact with the PTS2-
containing Gpd1p, a glycerol-3-phosphate dehydrogenase displaying a partial 
peroxisomal localization [87]. Apparently, all these PTS-less proteins reach the 
peroxisome matrix piggy-backed with the partners that do have one. Interestingly, for 
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the SOD1-CCS heterodimer this sorting pathway seems to be rather inefficient. Indeed, 
it was estimated that less than 10% of total CCS reaches the peroxisomes [85], a finding 
which according to those authors might reflect the existence of a weak PTS1 in CCS. An 
alternative explanation would be to assume that newly synthesized CCS interacts rapidly 
with the SOD1 protein (which lacks a PTS and therefore is not bound by PEX5) and that 
peroxisomal import of this heterodimer is a low efficiency process. In essence, this 
situation might be similar to those described in Section 3., where a PTS containing 
protein is co-expressed with a PTS-less partner, thus “diverting” the PTS protein (in this 
case, the CCS protein) from an immediate interaction with PEX5. The data for the yeast 
Gpd1p.Pnc1p heterodimer are more complex because the PTS2 signal of Gpd1p seems 
to be regulated by phosphorylation [92]. Thus, it is presently unclear whether the large 
extra-peroxisomal pools of both Gpd1p and Pnc1p that are detected in yeast cells under 
all experimental conditions tested reflect a low import efficiency of the heterodimeric 
complex or the phosphorylation status of Gpd1p. The cytosol/peroxisome distribution of 
LDHBx is unknown and thus, the import efficiency of the LDHBx-containing 
heterotetramers also remains undefined [86]. Regardless, these three examples show 
that peroxisomes can import oligomeric proteins even under conditions where PIM 
components are probably not stoichiometrically limiting. A main challenge now will be 
to determine the import kinetics of these proteins. 
 
7. Conclusion 
It is accepted that peroxisomes can import oligomeric proteins. However, the 
fact that they can does not imply that they generally do. Indeed, as discussed above, 
several observations made over the many years of research in this field are best 
explained by the monomeric protein import model. Nevertheless, there are also data 
suggesting that peroxisomes import at least minor amounts of some oligomeric proteins 
even under conditions where PIM components are not stoichiometrically limiting. 
Interestingly, the three known examples, CCS.SOD1, LDHBx.LDHB/A, and Gpd1p.Pnc1p 
are all hetero-oligomers in which only one of the subunits has a PTS. Thus, as with the 
monomers of some newly synthesized peroxisomal oligomeric proteins, they are bound 
and transported to the organelle by just one receptor molecule. 
 The jury is still out regarding the architecture of the docking/translocation 
machinery through which newly synthesized proteins are translocated into the 
peroxisome matrix. As emphasized here, a better characterization of its substrates will 
provide valuable information to understand how this machinery works. 
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Figure legends 
 
Figure 1. The monomeric and oligomeric protein import models. 
Peroxisomal matrix proteins are synthesized on free cytosolic ribosomes and folded into 
soluble monomers by the cytosolic chaperone machinery. Proteins that are monomeric 
in their native state (e.g., L-bifunctional protein; [93]) interact immediately with 
PEX5/PEX7 (PEX7 is not shown for simplicity). Proteins that are oligomeric in their native 
state can follow two pathways: 1) import into the peroxisome as monomers – the 
monomeric protein import model; or 2) oligomerization and subsequent import – the 
oligomeric protein import model. The experimental evidence supporting each of these 
models is provided in the main text. Note that oligomerization of some proteins hinders 
their interaction with PEX5. These proteins may only be targeted to the organelle as 
monomers. Also, oligomeric proteins that expose their PTSs might interact with several 
PEX5 molecules in the cytosol. How the docking/translocation machinery (DTM) might 
deal with these substrates is unknown. Folding of cofactor-containing proteins may be 
dependent [68] or independent [94] of the cofactor itself (e.g., FAD, thiamine 
pyrophosphate, heme). In the latter case, cofactor incorporation may occur in the 
cytosol and/or peroxisome. 
 
 
Table 1. Studies reporting import of peroxisomal matrix proteins as oligomers.  
 
Table 2. Studies reporting import of peroxisomal matrix proteins as monomers. 
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Table 1. Studies reporting import of peroxisomal matrix proteins as oligomers.  
 
Protein Organism 
Quaternary  
Structure 
Refs 
Chloramphenicol acetyltransferase engineered bacterial protein Trimeric [43] 
3-ketoacyl-CoA thiolase Saccharomyces cerevisiae Dimeric [67] 
Alanine-glyoxylate aminotransferase Homo sapiens Dimeric [95] 
Malate dehydrogenase Saccharomyces cerevisiae Dimeric [96] 
Isocitrate lyase 
Gossypium hirsutum 
Tetrameric [97] Ricinus communis 
Brassica napus 
Catalase 
Candida boidinii Tetrameric [98] 
Homo sapiens Tetrameric [99] 
Dihydroxyacetone synthase 
Candida boidinii Dimeric [69] 
Hansenula polymorpha Dimeric [78] 
3,2-trans-enoyl-CoA isomerase Saccharomyces cerevisiae Monomeric [100] 
Acyl-CoA oxidase Yarrowia lipolytica Heteropentameric [68] 
Peroxisomal membrane protein LPX1 Saccharomyces cerevisiae Dimeric [101,102] 
Cu/Zn Superoxide Dismutase/ Copper 
chaperone of SOD1 
Rattus norvegicus Heterodimeric [85] 
HEX Neurospora crassa Hexameric [83] 
Lactate dehydrogenase Homo sapiens Heterotetrameric [86] 
Nicotinamidase /Glycerol-3-phosphate 
dehydrogenase 1 
Saccharomyces cerevisiae Heterodimeric [87] 
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Table 2. Studies reporting import of peroxisomal matrix proteins as monomers. 
 
Protein Organism 
Quaternary 
Structure 
Refs 
Catalase Rattus norvegicus Tetrameric [61] 
Malate synthase Cucumis sativus Octameric [60] 
Alcohol oxidase 
Candida boidinii Octameric [59,69] 
Hansenula polymorpha Octameric 
[78,103,10
4] 
Pichia pastoris Octameric [105] 
Isocitrate lyase Cucurbita pepo Tetrameric [56] 
Dehydrogenase/reductase  
SDR family member 4 
Sus scrofa Tetrameric [76] 
Soluble epoxide hydrolase Homo sapiens Dimeric [77] 
Acyl-CoA oxidase Mus musculus Dimeric [63] 
Urate oxidase Mus musculus Tetrameric [63] 
 
  
 
mRNA 
Cofactor 
Cofactor 
or 
Cytosolic 
localization 
Figure 1 
or 
? 
